The News and Observer
Editorials Newsletter
Pfizer, Allergan merger hits US taxpayers

A deal that would create the world’s largest drug company would also help Pfizer dodge billions of dollars in US taxes. Congress should halt this and other ‘corporate inversions.’

The Pfizer logo appears above a trading post on the floor of the New York Stock Exchange on Monday. Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world’s largest drugmaker.
James Taylor, an American voice honored

Contact Us   |   About Us   |   Privacy Policy   |   Terms of Use   |   About Our Ads   |   Copyright   |   Place an Ad

Copyright © %%XTYEAR%% · News & Observer. All Rights Reserved.

You are receiving this email because you opted-in on

%%Member_City%%, %%Member_State%% %%Member_PostalCode%%

We respect your right to privacy. View our policy.
If you believe this email has been sent to you in error, click here to safely unsubscribe.

Manage Newsletter Subscriptions   |   Update Profile Settings   |   Forward to a Friend